Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk

Read MoreHide Full Article

For Immediate Release

Chicago, IL – August 18, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Pfizer (NYSE: PFE Free Report), TJX Companies (NYSE: TJX Free Report), Honda (NYSE:HMC Free Report), American Electric (NYSE:AEP Free Report) and Novo Nordisk (NYSE: NVO Free Report).  

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday’s Analyst Blog:

Top Analyst Reports for Pfizer, TJX Companies, Honda & More

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer (NYSE: (PFE - Free Report) Free Report), TJX Companies (NYSE: (TJX - Free Report) Free Report) and Honda (NYSE:(HMC - Free Report) Free Report). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Pfizer shares have underperformed the peer group as well as the broader market over the past year (the stock is down -5.2% over the last year vs. a +1.7% increase for the Zacks Large-Cap Pharmaceuticals industry and the +12.5% gain for the S&P 500 index) on continued drug pricing uncertainty that have refused to go away even after the election.

Pfizer’s second-quarter results were mixed with earnings beating expectations even as sales came in lower than projected. The drugmaker continues to face headwinds in the form of genericization of key drugs, lost alliance revenues, pricing pressure and rising competition, which are hurting the top line.

But the Zacks analyst thinks that new products like Ibrance, contribution from acquisitions, cost-cutting efforts and share buybacks should help the company achieve its guidance. Pfizer also boasts a strong pipeline and expects approximately 25 to 30 drug approvals over the next five years, including around 15 products that have blockbuster potential.

(You canread the full research report on Pfizer here >>>).

Shares of TJX Companies have underperformed the Zacks Discount Stores industry over the last one month, gaining +2.3% vs. +3.8%. The company’s second-quarter results exceeded expectations, driven by improved traffic and margin improvements, as well as higher market share. The company also raised its fiscal 2018 earnings guidance.

The Zacks analyst likes the company’s brand enhancing initiative, aggressive store opening strategy and improving e-commerce business. However, the company is facing disappointing comps growth of late. The company is also facing margin pressure due to higher payroll and pension related costs. Currency headwinds are another concern.

(You can read the full research report on TJX Companies here >>>).

Strong Buy-rated Honda’s shares have lagged its auto peers over the last one year losing -7.5% vs. -5.1%. However, Honda reported better-than-expected earnings in the first quarter of fiscal 2018. Both earnings and revenues rose year over year too. The year-over-year increase can be attributed to higher revenues in financial services, motorcycle business operations and foreign currency conversion effects. Also, record-high production in the first-half of calendar year 2017 outside Japan is aiding Honda.

Moreover, the company has been focusing on infrastructural development, new product introductions and car launches in Asia, North and South America. Honda has also planned to launch fuel cell vehicles in U.S. and European markets. These efforts are expected to popularize the company and attract more customers, which in turn will boost the revenue figure. It is also undertaking frequent collaborations in order to expand its business.

(You can read the full research report on Honda here >>>).

Other noteworthy reports we are featuring today include American Electric (NYSE:(AEP - Free Report) Free Report) and Novo Nordisk (NYSE: (NVO - Free Report) Free Report).

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today. Learn more >>

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.

Get the full Report on PFE - FREE

Get the full Report on TJX - FREE

Get the full Report on HMC - FREE

Get the full Report on AEP - FREE

Get the full Report on NVO - FREE

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.